The use of a cytokine panel to define the long-term risk stratification of heart failure/death in patients presenting with chest pain to the emergency department

Clinical Biochemistry

Volumn 43, Issue 4-5, 2010, Pages 505-507

  Kavsak, Peter A ^a   Newman, Alice M ^b   Ko, Dennis T ^b   MacRae, Andrew R ^c   Jaffe, Allan S ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d MAYO CLINIC   (United States)

Author keywords

Acute coronary syndrome; Cytokine panel; Heart failure; Risk stratification, ED

Indexed keywords

CYTOKINE; EDETIC ACID; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEART DEATH; HEART FAILURE; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; RISK ASSESSMENT; THAWING; THORAX PAIN; UPREGULATION;

AGED; CHEST PAIN; CYTOKINES; DEATH; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; RISK FACTORS; TIME FACTORS;

EID: 76749166949     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.11.004     Document Type: Article

References (10)

1. Scirica B.M., Morrow D.A., Cannon C.P., et al. Clinical application of C-reactive protein across the spectrum of acute coronary syndromes. Clin. Chem. 53 (2007) 1800-1807
2. Kavsak P.A., Ko D.T., Newman A.M., et al. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide. Clin. Chem. 53 (2007) 2112-2118
3. Garratt A.N., Ozcelik C., and Birchmeier C. ErbB2 pathways in heart and neural diseases. Trends Cardiovasc. Med. 13 (2003) 80-86
4. Mälarstig A., Eriksson P., Hamsten A., et al. Raised interleukin-10 is an indicator of poor outcome and enhanced systemic inflammation in patients with acute coronary syndrome. Heart 94 (2008) 724-729
5. Heeschen C., Dimmeler S., Hamm C.W., et al. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J. Am. Coll. Cardiol. 45 (2005) 229-237
6. LaFramboise W.A., Scalise D., Stoodley P., et al. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am. J. Physiol., Cell Physiol. 292 5 (2007 May) C1799-1808
7. Kavsak P.A., Newman A.M., Lustig V., et al. Long-term health outcomes associated with detectable troponin I concentrations. Clin. Chem. 53 (2007) 220-227
8. Berrahmoune H., Lamont J.V., Herbeth B., et al. Biological determinants of reference values for plasma interleukin-8, monocyte chemoattractant protein-1, epidermal growth factor, and vascular endothelial growth factor: results from the STANISLAS cohort. Clin. Chem. 52 (2006) 504-510
9. Kenis G., Teunissen C., De Jongh R., et al. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine 19 (2002) 228-235
10. Lind L., Wallentin L., Kempf T., et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Eur. Heart J. 30 (2009) 2346-2353